Calla TMVr System, our comprehensive transfemoral DMR solution, will be unveiled to the clinical community in a podium presentation in the Innovation Theatre on November 4, 3PM local time. Please come and check us out!
The Transcatheter Cardiovascular Therapeutics (TCT) conference, is the Cardiovascular Research Foundation’s (CRF) annual scientific symposium and the world’s foremost educational forum specializing in interventional cardiovascular medicine.
We are proud to present the Vesalius transfemoral DMR solution during TCT on behalf of a great 8 R&D engineers working on the Calla TMVr System.
Online access is free this year. You can register here.